ATE141508T1 - Zusammensetzung zur förderung des lipidmetabolismus - Google Patents

Zusammensetzung zur förderung des lipidmetabolismus

Info

Publication number
ATE141508T1
ATE141508T1 AT94104839T AT94104839T ATE141508T1 AT E141508 T1 ATE141508 T1 AT E141508T1 AT 94104839 T AT94104839 T AT 94104839T AT 94104839 T AT94104839 T AT 94104839T AT E141508 T1 ATE141508 T1 AT E141508T1
Authority
AT
Austria
Prior art keywords
lipid metabolism
composition
promoting lipid
chem
formula
Prior art date
Application number
AT94104839T
Other languages
German (de)
English (en)
Inventor
Kazumi Ogata
Takahiro Sakaue
Yasuko Umegaki
Rie Nagao
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE141508T1 publication Critical patent/ATE141508T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94104839T 1993-03-31 1994-03-27 Zusammensetzung zur förderung des lipidmetabolismus ATE141508T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7381493 1993-03-31

Publications (1)

Publication Number Publication Date
ATE141508T1 true ATE141508T1 (de) 1996-09-15

Family

ID=13529009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94104839T ATE141508T1 (de) 1993-03-31 1994-03-27 Zusammensetzung zur förderung des lipidmetabolismus

Country Status (8)

Country Link
US (1) US5474991A (enExample)
EP (1) EP0617963B1 (enExample)
KR (1) KR100272483B1 (enExample)
AT (1) ATE141508T1 (enExample)
CA (1) CA2116198A1 (enExample)
DE (1) DE69400382T2 (enExample)
ES (1) ES2091057T3 (enExample)
TW (1) TW252918B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922335A (en) * 1995-05-15 1999-07-13 Avon Products, Inc. Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
US5866147A (en) * 1995-05-15 1999-02-02 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
KR100612398B1 (ko) * 2000-11-14 2006-08-16 바이탈 헬스 사이언시즈 피티와이 리미티드 포스페이트 유도체의 착체
JP4745608B2 (ja) * 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 電子伝達剤のリン酸誘導体を用いた皮膚治療
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
US20040018959A1 (en) * 2002-05-02 2004-01-29 Randall S. Hickle System and methods of lipid removal from the body
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
MXPA05007278A (es) * 2003-01-17 2005-09-30 Vital Health Sciences Pty Ltd Compuestos que tienen propiedades anti-proliferativas.
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
ATE495730T1 (de) 2004-03-03 2011-02-15 Vital Health Sciences Pty Ltd Alkaloid-formulierungen
EP1861091B1 (en) * 2005-03-03 2013-12-11 Vital Health Sciences Pty Ltd. Compounds having lipid lowering properties
MX2007010492A (es) * 2005-03-03 2007-11-08 Vital Health Sciences Pty Ltd Compuestos que tienen propiedades anticancer.
EP2548581A3 (en) * 2005-06-17 2013-02-20 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
BRPI0621081A2 (pt) * 2005-12-23 2011-11-29 Vital Health Sciences Pty Ltd método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos
ES2999020T3 (en) 2010-02-05 2025-02-24 Phosphagenics Ltd Carrier comprising non-neutralised tocopheryl phosphate
SG184181A1 (en) 2010-03-30 2012-10-30 Phosphagenics Ltd Transdermal delivery patch
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINOCHINOLINE AS A KINASEHEMMER
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JPH0781138B2 (ja) * 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
JP2526059B2 (ja) * 1987-04-28 1996-08-21 千寿製薬株式会社 抗潰瘍剤
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
UA19385A1 (uk) * 1989-04-27 1997-12-25 Сендзю Фармасьютікал Ко. Лтд. Фофоліпідhі похідhі та композиція, яка має аhтиоксидаhтhу та іhгібуючу активhість щодо пероксидів ліпідів
US5053222A (en) * 1989-06-07 1991-10-01 Shiseido Company Ltd. Hair cosmetic composition
US5231090A (en) * 1990-07-30 1993-07-27 University Of Miami Treatment for hypercholesterolemia
CA2099346A1 (en) * 1992-07-17 1994-01-18 Shinji Ohmori Lipid metabolism improving composition

Also Published As

Publication number Publication date
ES2091057T3 (es) 1996-10-16
DE69400382D1 (de) 1996-09-26
EP0617963B1 (en) 1996-08-21
KR100272483B1 (ko) 2000-11-15
DE69400382T2 (de) 1996-12-19
TW252918B (enExample) 1995-08-01
CA2116198A1 (en) 1994-10-01
US5474991A (en) 1995-12-12
EP0617963A1 (en) 1994-10-05
KR940021059A (ko) 1994-10-17

Similar Documents

Publication Publication Date Title
DE69400382D1 (de) Zusammensetzung zur Förderung des Lipidmetabolismus
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
NZ214610A (en) Piperazine derivatives and pharmaceutical compositions
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DK260588A (da) Heterocykliske ketoner
ATE173626T1 (de) Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
PT916651E (pt) DERIVADOS DE áCIDO FENILALQUILCARBOXILICO
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
ATE64391T1 (de) Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
DE69233255D1 (de) Carbamatanalogen von thiaphysovenin, pharmazeutische zusammensetzungen und verfahren zur hemmung von cholinesterasen
FI834791A0 (fi) Foerfarande foer framstaellning av pyrinderivat
AU3895689A (en) Cyclic sulfur-containing amino acid derivatives
ATE171622T1 (de) Antiallergische zusammensetzung enthaltend eine phosphorsäurediester-verbindung
ATE149494T1 (de) Benzopyranderivate und verfahren zu deren herstellung
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
ATE66475T1 (de) Aromatische thioaether.
FR2691967B1 (fr) Nouveaux composes pyrrolothienopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties